Immunocore Holdings plc has grown revenue 32% a year over three years and 82% a year over five. Revenue growth, 3-year annual rate: +32% (Biotechnology median +21%). Revenue growth, 5-year rate: +82%, growth has slowed since the five-year average. Years of annual history on file: 5, FY2021 to FY2025, as filed.

IMCRImmunocore Holdings plc

HealthcareUSD

$37.11

$27.7952 weeks$40.22

Is it growing?

Is IMCR growing?

Immunocore Holdings plc has grown revenue 32% a year over three years and 82% a year over five.

+32%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +82%
Revenue growth, 5-year rate · +32% over three · growth has slowed since the five-year average
Years of annual history on file: 5
Years of annual history on file · FY2021 to FY2025, as filed

Details›